ActoGeniX actogenix.com


Public lists: Pharma Startups (4729)

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics. ActoGeniX's mission is to develop and commercialize innovative biological therapies, to improve the treatment and well-being of patients with gastrointestinal, immunological and metabolic diseases.

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics. ActoGeniX's mission is to develop and commercialize innovative biological therapies, to improve the treat...Show all

Company (Acquired)

Phone:

Fax:

Technologiepark 4

Zwijnaarde, 9052
Belgium

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ActoGeniX $64.8M Feb 13, 2015
Aphios $0M Oct 20, 2008
Dynogen Pharmaceuticals $67.3M Dec 14, 2007
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ActoGeniX Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Induction of mucosal tolerance to antigens Mar 17, 2014 Jan 10, 2017 Patent
Induction of mucosal tolerance to antigens Mar 17, 2014 Dec 27, 2016 Patent
Modified gram positive bacteria and uses thereof Sep 21, 2012 Oct 04, 2016 Patent
Modified gram positive bacteria and uses thereof Sep 21, 2012 May 24, 2016 Patent
Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis Aug 30, 2006 Apr 28, 2015 Patent
See all 13 patents